-
Article | 2025.05.16
European Consortium for Zoonotic and Emerging Viruses - EURL-PH-ERZV
Member of the Consortium of EU Public Health Reference Laboratories for emerging, rodent-borne and zoonotic viral pathogens (EURL-PH-ERZV)
-
CNR/CCOMS | 2019.11.19
Emerging animal pathogens in humans
World Organization for Animal Health - Collaborating Center (WOAHCC) for the "detection and identification in humans of emerging animal pathogens and development of tools for their diagnoses".The Environment and Infectious Risks Unit, Laboratory for Urgent Response to Biological Threats, and Pathogen Discovery Laboratory host this WOAHCC.HeadsJean-Claude ManuguerraMarc EloitDetection and...
-
Vidéo | 2025.05.22
Measles: why is the vaccine vital?
Measles wipes out our immunity!Yasmine Belkaid, Director General of the Institut Pasteur, sounds the alarm during her appearance on Lundis du 1: measles is not a “simple childhood disease”. It literally erases the memory of our immune system.In a word, it resets your body to zero. Even past vaccines and infections no longer protect you.In a context of growing vaccine mistrust, this message is...
-
Article | 2017.01.06
Internship Grants Calmette&Yersin
Develop your expertise through an internship within the Pasteur Network
-
Document de presse | 2025.05.23
Launch of the European Vaccines Hub for Pandemic Readiness, a new European public-private partnership for public health-relevant vaccine development
The Health Emergency Preparedness and Response Authority (HERA) of the European Commission, through the European Health and Digital Executive Agency (HaDEA) supports the establishment of the “European Vaccines Hub (EVH) for Pandemic Readiness”, a pan-European center dedicated to advancing public-health–relevant vaccine development. The Grant Agreement has been signed today, marking a...
-
Document de presse | 2025.04.28
HIV: genetic characteristics associated with sustained HIV remission after stopping treatment
Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But some individuals, known as "post-treatment controllers," are able to maintain an undetectable viral load even after stopping treatment. In a study funded by ANRS Emerging Infectious Diseases (ANRS...
-
News | 2025.05.19
Institut Pasteur To Host International Meeting on Mirror Biology
The Institut Pasteur will host an international conference on June 12-13, 2025 addressing the potentially unprecedented risks of mirror life, organized in partnership with the Mirror Biology Dialogues Fund. The conference marks the first in a series of global meetings planned throughout 2025 and 2026 to explore pathways for research and policy to mitigate the potential risks of mirror life.
-
News | 2025.05.30
Deep Tech Venture Builder: the project PICASSO from the Institut Pasteur joins EIT Health program
Specifically designed to support academic teams with deep tech solutions, EIT Health’s DTVB provides start-ups with the right support to overcome the most frequent hurdles experienced when launching to market. Notoriously known as the “Valley of Death” – where many promising ideas fail to transition out of academic environments – successfully navigating this stage requires overcoming the most...
-
News | 2025.05.30
Institut Pasteur deploys MinoSuiteTM “Pioneer” platform from startup Minos Biosciences, developing next-generation cell analysis technology
With the deployment of its MinoSuiteTM Pioneer platform at the Institut Pasteur, within the Dynamics of Host-Pathogen Interactions unit, headed by Dr. Jost Enninga, deep-tech startup Minos Biosciences has officially launched its Early Access Program. The strategic collaboration between Minos Biosciences and the teams of Jost ENNINGA and Milena HASAN from the Institut Pasteur, partially funded by...
-
Article | 2019.02.22
PPU-Oxford Program
"Chimie Biologique"Linking Chemistry and Microbiology to Fight Human Diseases
